Henry Schein (NASDAQ:HSIC) Shares Cross Above 200 Day Moving Average - What's Next?

Key Points

• Henry Schein shares rose above their 200-day moving average, reaching $87.33 and last trading at $86.99, compared with the 200-day average of $82.16.
• Analysts hold a generally positive view, with a consensus “Moderate Buy” rating and an average price target of $93.27; Barclays raised its target to $100.
• The company exceeded quarterly expectations, reporting $1.27 EPS and $3.46 billion in revenue, with revenue up 6.7% year over year; full-year guidance is $5.29–$5.39 EPS.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report)'s share price crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $82.16 and traded as high as $87.33. Henry Schein shares last traded at $86.99, with a volume of 963,226 shares.

Wall Street Analyst Weigh In

HSIC has been the topic of several recent analyst reports. Wall Street Zen upgraded Henry Schein from a "hold" rating to a "buy" rating in a report on Monday, August 17th. UBS Group set a $94.00 target price on Henry Schein and gave the company a "neutral" rating in a research note on Wednesday, August 5th. Stifel Nicolaus set a $95.00 price target on Henry Schein in a report on Wednesday, August 5th. Leerink Partners set a $92.00 price target on Henry Schein and gave the stock a "market perform" rating in a report on Wednesday. Finally, Barclays reaffirmed an "overweight" rating and set a $100.00 price target (up from $86.00) on shares of Henry Schein in a research report on Thursday, August 6th. Nine investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $93.27.

Henry Schein Stock Performance

The stock has a market cap of $9.70 billion, a P/E ratio of 25.36, a price-to-earnings-growth ratio of 1.54 and a beta of 0.84. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.32 and a quick ratio of 0.73. The stock's 50 day simple moving average is $87.45 and its two-hundred day simple moving average is $82.16.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.03. Henry Schein had a net margin of 2.96% and a return on equity of 15.97%. The company had revenue of $3.46 billion during the quarter, compared to the consensus estimate of $3.37 billion. During the same quarter in the prior year, the firm earned $1.10 earnings per share. The firm's revenue was up 6.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. As a group, research analysts forecast that Henry Schein, Inc. will post 5.36 EPS for the current year.

Hedge Funds Weigh In On Henry Schein

Large investors have recently added to or reduced their stakes in the company. Operose Advisors LLC bought a new stake in shares of Henry Schein in the second quarter valued at about $33,000. Trust Co. of Vermont acquired a new position in shares of Henry Schein during the second quarter worth about $42,000. Versant Capital Management Inc boosted its position in shares of Henry Schein by 175.4% during the second quarter. Versant Capital Management Inc now owns 617 shares of the company's stock worth $52,000 after buying an additional 393 shares during the period. EverSource Wealth Advisors LLC grew its holdings in shares of Henry Schein by 167.4% during the first quarter. EverSource Wealth Advisors LLC now owns 936 shares of the company's stock worth $69,000 after buying an additional 586 shares in the last quarter. Finally, Contravisory Investment Management Inc. bought a new position in shares of Henry Schein during the second quarter worth about $84,000. Institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc NASDAQ: HSIC is a global provider of health care products and services serving dental and medical professionals, laboratories, health care institutions and veterinary practices. The company operates primarily as a distributor, helping customers obtain medical, dental and veterinary supplies, equipment, pharmaceuticals and related products.

In addition to product distribution, Henry Schein provides technology solutions and value-added services designed to support practice management, clinical workflows, procurement, compliance and business operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.